{"id":"W2970358718","doi":"10.1038/s41375-019-0559-9","title":"MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Bendamustine; Medicine; Obinutuzumab; Internal medicine; Minimal residual disease; Rituximab; Follicular lymphoma; Hazard ratio; Gastroenterology; Refractory (planetary science); Surgery; Oncology; Lymphoma; Confidence interval; Leukemia; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001001703,0.0003656299,0.0007163906,0.0003108298,0.00004276645,0.00003560727,0.0002250687,0.0002757975,0.001051151],"category_scores_gemma":[0.0005165708,0.0002202972,0.0001729255,0.0005658244,0.00007019728,0.00009608968,0.00008658147,0.0005111938,0.0005582385],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00395001,"about_ca_system_score_gemma":0.002069902,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001105244,"about_ca_topic_score_gemma":0.0007196342,"domain_scores_codex":[0.9972551,0.0003711223,0.0006985134,0.000571252,0.0005327002,0.0005713378],"domain_scores_gemma":[0.9977775,0.001018413,0.0001446135,0.0008679281,0.00005023424,0.0001413663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9319088,0.001496053,0.03768291,0.0001888976,0.0001259823,0.008127376,0.00468216,0.0003257966,0.0007931988,0.0000958595,0.008447879,0.006125047],"study_design_scores_gemma":[0.3465917,0.006447457,0.5895308,0.0007726518,0.0002104821,0.0003195648,0.0008018886,0.001044389,0.0006535673,0.00003380273,0.05309986,0.0004937956],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936818,0.0005494192,0.000001387829,0.00175348,0.0005150503,0.001990697,0.00003918331,0.00004916014,0.001419781],"genre_scores_gemma":[0.9918016,0.0000947063,0.0002438623,0.001860276,0.0003986039,0.0004795976,0.00006617351,0.00004813206,0.00500707],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5853171,"threshold_uncertainty_score":0.9998736,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0195550374906363,"score_gpt":0.2789786274909884,"score_spread":0.2594235900003521,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}